Term ends Mar 23, 2032 · Medium confidence
20-year base term ends Mar 23, 2032
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 9,119,809), so the cap could be lower.
Mar 23, 2012
Mar 23, 2032
Mar 15, 2016
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 23, 2012, when application 13/429,292, the earliest non-provisional in its chain, was filed (this one was filed May 5, 2015) | Mar 23, 2032 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,119,809, US 9,289,394, US 9,603,808, US 9,603,809) | resolves to Mar 23, 2032, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 23, 2032 | Medium confidence |
This family
| US 9,028,868 | In force no later than Mar 2032 | no later than Mar 2032 |
| US 8,927,010 | In force no later than Mar 2032 | no later than Mar 2032 |
| US 8,916,588 | In force no later than Mar 2032 | no later than Mar 2032 |
| US 9,119,809 | In force no later than Mar 2032 | no later than Mar 2032 |
| US 9,034,902 | In force no later than Mar 2032 | no later than Mar 2032 |
| US 9,023,389 | In force no later than Mar 2032 | no later than Mar 2032 |
| US 9,283,214 | this patent Mar 2032 | Mar 2032 |
| US 9,603,808 | In force Mar 2032 | Mar 2032 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 30, 2015 Reel 35941, frame 619 | Zhang, Feng | Formulation Technologies, LLC Dba Pharmaform LLC | Assignment of Assignor's Interest |
| Jun 30, 2015 Reel 35941, frame 702 | Highland Therapeutics, Inc. | Ironshore Pharmaceuticals & Development, Inc. | Assignment of Assignor's Interest |
| Jun 30, 2015 Reel 35941, frame 726 | Lickrish, David | Ironshore Pharmaceuticals & Development, Inc. | Assignment of Assignor's Interest |
| Jun 30, 2015 Reel 36040, frame 783 | Formulation Technologies L.L.C. Dba Pharmaform | Highland Therapeutics Inc. | Assignment of Assignor's Interest |
| Jul 21, 2015 Reel 36140, frame 149 | Ironshore Pharmaceuticals & Development, Inc. | Eastern Capital Limited | Patent Security Agreement |
| Jan 23, 2017 Reel 41047, frame 474 | Eastern Capital Limited | Ironshore Pharmaceuticals & Development, Inc. | Release of Security Interest |
| Jan 23, 2017 Reel 41048, frame 299 | Ironshore Pharmaceuticals & Development, Inc.; Highland Therapeutics Inc.; North Sound Pharmaceuticals, Inc.; Ironshore Pharmaceuticals Inc. | U.S. Bank National Association | Security Interest |
| Sep 3, 2024 Reel 68826, frame 711 | Ironshore Pharmaceuticals & Development, Inc. | Biopharma Credit PLC | Patent Security Agreement |
| Dec 5, 2025 Reel 73133, frame 245 | U.S. Bank Trust Company, National Association | Ironshore Pharmaceuticals & Development, Inc.; Highland Therapeutics Inc.; North Sound Pharmaceuticals, Inc.; Ironshore Pharmaceuticals Inc. | Release of Security Interest |
| Dec 5, 2025 reel/frame not recorded | U.S. Bank Trust Company, National Association | Ironshore Pharmaceuticals & Development, Inc. | Release of Security Interest |
| Dec 5, 2025 reel/frame not recorded | U.S. Bank Trust Company, National Association | Highland Therapeutics Inc. | Release of Security Interest |
| Dec 5, 2025 reel/frame not recorded | U.S. Bank Trust Company, National Association | North Sound Pharmaceuticals, Inc. | Release of Security Interest |
| Dec 5, 2025 reel/frame not recorded | U.S. Bank Trust Company, National Association | Ironshore Pharmaceuticals Inc. | Release of Security Interest |
| Dec 23, 2025 Reel 73302, frame 334 | Collegium Pharmaceutical, Inc.; Biodelivery Sciences International, Inc.; Ironshore Pharmaceuticals & Development, Inc. | Truist Bank, a North Carolina Chartered Bank | Security Interest |
| Dec 23, 2025 Reel 73308, frame 416 | Biopharma Credit PLC | Ironshore Pharmaceuticals & Development, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 9,119,809, US 9,289,394, US 9,603,808, US 9,603,809, ends no earlier than this term, so it caps nothing.